CureVac: Over 100 Million vaccines to be produced
TÜBINGEN – CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic …
Continue readingTÜBINGEN – CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic …
Continue readingBremen/Augsburg – At the Capital Market Day of space technology group OHB SE (Prime Standard, ISIN DE0005936124), Augsburg-based start-up Rocket …
Continue readingNEW YORK/MAINZ – Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Medicines Agency (EMA) approved storage of …
Continue readingBEIJING – China’s top ride-hailing app dropped Swedish fashion retailer H&M from its listings as Chinese celebrities stopped endorsing foreign …
Continue readingBERLIN/SHANGHAI– The organizers of ITB China have announced to host an offline industry gathering at the end of June in …
Continue reading